Page last updated: 2024-09-04

aclacinomycin and Cell Transformation, Neoplastic

aclacinomycin has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobichon, H; Gillet, R; Trentesaux, C1

Other Studies

1 other study(ies) available for aclacinomycin and Cell Transformation, Neoplastic

ArticleYear
Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
    Biology of the cell, 2002, Volume: 94, Issue:4-5

    Topics: Aclarubicin; Adjuvants, Immunologic; Antibody Specificity; Cell Compartmentation; Cell Nucleus; Cell Transformation, Neoplastic; DNA-Binding Proteins; Dose-Response Relationship, Drug; Erythrocytes; Erythroid Precursor Cells; Erythroid-Specific DNA-Binding Factors; Erythropoiesis; GATA1 Transcription Factor; Gene Expression Regulation, Leukemic; Hemoglobins; Humans; K562 Cells; Leukemia; Microscopy, Confocal; Phosphoric Monoester Hydrolases; Phosphorylation; Transcription Factors

2002